1020795-72-5Relevant articles and documents
Biarylpyrazolyl oxadiazole as potent, selective, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity
Suk, Ho Lee,Hee, Jeong Seo,Lee, Sung-Han,Myung, Eun Jung,Park, Ji-Hyun,Park, Hyun-Ju,Yoo, Jakyung,Yun, Hoseop,Na, Jooran,Suk, Youn Kang,Song, Kwang-Seop,Kim, Min-Ah,Chang, Chong-Hwan,Kim, Jeongmin,Lee, Jinhwa
scheme or table, p. 7216 - 7233 (2009/11/30)
Since the CB1 cannabinoid receptor antagonist 1 (SR141716, rimonabant) was previously reported to modulate food intake, CB1 antagonism has been considered as a new therapeutic target for the treatment of obesity. In the present study, biarylpyrazole analo